We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Febit Acquires License From OGT
News

Febit Acquires License From OGT

Febit Acquires License From OGT
News

Febit Acquires License From OGT

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Febit Acquires License From OGT"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

febit biotech gmbh has announced that it has acquired a license from Oxford Gene Technology (OGT) from Oxford, UK.

The acquired license refers to patents on technologies that were developed in the 80ies by OGT’s founder, Professor Edwin M. Southern.

The "Southern array patents" are the fundamental patents covering the manufacture and use of DNA microarrays in genetic and genomic research.

"We are delighted about the successful conclusion of the agreement with OGT, which further strengthens our IP position to successfully market our GENIOM® technology worldwide," says Cord F. Stahler, President & CEO of febit biotech gmbh.

Dr. Mike Evans, Chief Executive of OGT adds, "We are happy to support febit biotech’s technology by granting this license and thus further the use of microarray technology."

Advertisement